Inovio Pharma (INO) Misses Q1 EPS by 4c, Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Epidemic response group to invest up to $384 mln in Novavax's COVID-19 vaccine
May 11, 2020 4:07 PM EDT(Reuters) - The Coalition for Epidemic Preparedness Innovations (CEPI) will invest up to $384 million to help develop and produce Novavax Inc's (NASDAQ: NVAX) COVID-19 vaccine candidate, the company said on Monday, sending its shares up 31.2% in extended trading.
CEPI, which was set up to fight emerging epidemics, said in March it would invest... More
Inovio Pharmaceuticals (INO) PT Raised to $9 at RBC Capital
May 7, 2020 6:14 AM EDTRBC Capital analyst Gregory Renza raised the price target on Inovio Pharmaceuticals (NASDAQ: INO) to $9.00 (from $7.00) while maintaining a Sector Perform rating.... More
